Next 10 |
home / stock / sdmhf / sdmhf news
2024-04-01 09:22:56 ET More on Sartorius Stedim Biotech S.A. Sartorius Stedim Biotech S.A. (SDMHF) Q4 2023 Earnings Call Transcript Historical earnings data for Sartorius Stedim Biotech S.A. Dividend scorecard for Sartorius Stedim Biotech S.A. Financial infor...
2024-01-26 15:51:05 ET Sartorius Stedim Biotech S.A. (SDMHF) Q4 2023 Earnings Call Transcript January 26, 2024 07:00 AM ET Company Participants Dr. Joachim Kreuzburg - IR Rene Faber - Head of Bioprocess Solutions Division & Member Conference Call Participan...
2024-01-26 10:07:59 ET More on Sartorius Stedim Biotech S.A. Historical earnings data for Sartorius Stedim Biotech S.A. Dividend scorecard for Sartorius Stedim Biotech S.A. Financial information for Sartorius Stedim Biotech S.A. Read the full article on See...
2023-12-05 22:50:05 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-11-07 17:07:59 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-10-20 17:03:02 ET Sartorius Stedim Biotech S.A. (SDMHF) Q3 2023 Earnings Conference Call October 20, 2023, 6:30 AM ET Company Participants Joachim Kreuzburg - Chief Executive Officer Rainer Lehmann - Chief Financial Officer Rene Faber - Chief Executive Offic...
2023-10-19 03:12:00 ET Summary Drugmakers don’t have to dominate a healthcare portfolio. Equity investors should cast a wide net across the sector to find innovation and growth. When pharmaceutical companies conduct tests on new drugs, they typically outsource clinical tria...
2023-09-19 10:00:00 ET Summary I am a 24-year-old investor aiming for financial freedom through long-term investing in companies with good management and growth potential. I made changes to the portfolio, buying stocks such as UFP Industries and Ulta Beauty, and selling stocks lik...
2023-07-21 17:47:09 ET Sartorius Stedim Biotech S.A. (SDMHF) Q2 2023 Earnings Conference Call July 21, 2023 09:30 AM ET Company Participants Joachim Kreuzburg - CEO Rainer Lehmann - CFO René Fáber - Head, Bioprocess Solutions and CEO, Sartorius Stedim B...
2023-07-21 14:35:23 ET Sartorius Stedim Biotech S.A. press release ( OTCPK:SDMHF ): 1H GAAP EPS of €2.62. Revenue of €1.41B (-18.0% Y/Y). For further details see: Sartorius Stedim Biotech S.A. GAAP EPS of €2.62, revenue of €1.41B
News, Short Squeeze, Breakout and More Instantly...
Sartorius Stedim Biotech Company Name:
SDMHF Stock Symbol:
OTCMKTS Market:
Nine-month results 2022 of Sartorius Stedim Biotech PR Newswire Sales revenue up 17.0 percent in constant currencies, underlying EBITDA margin at 35.0 percent Overall market situation characterized by innovations and strong growth drivers; current development as ex...
Sartorius Stedim Biotech to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions PR Newswire UK-based Albumedix Ltd. is a leader in the field of recombinant albumin-based solutions and a highly innovative and profitable company Re...
Half-year results 2022 of Sartorius Stedim Biotech PR Newswire AUBAGNE, France , July 21, 2022 Sales revenue up 22.1 percent in constant currencies, underlying EBITDA margin 35.2 percent 2022 outlook confirmed: Sales revenue expected...